Skip to main content
Last Updated
In the Matter of Epichouse, LLC, a corporation, also d/b/a First Class Herbalist CBD, Cobalt Serum, Cobalt Enhance, and Cobalt Cream; and John Le, individually and as an owner and officer of Epichouse LLC
FTC Matter/File Number
202 3094
Civil Action Number
Enforcement Type
Part 2 Consents

Case Summary

In December 2020, the FTC announced its first law enforcement crackdown on deceptive claims in the growing market for cannabidiol (CBD) products. The Commission took action against six sellers of CBD-containing products for allegedly making a wide range of scientifically unsupported claims about their ability to treat serious health conditions, including cancer, heart disease, hypertension, Alzheimer’s disease, and others. A summary of the proposed orders settling the agency’s respective complaints can be found on the FTC’s website as a link to each case. The FTC announced final approval of all six orders in March 2021.

Epichouse LLC. The proposed administrative order prohibits the respondents from making certain prevention, treatment, or safety claims about dietary supplements, foods, and drugs, unless they have the human clinical testing to substantiate the claims. It requires them to have competent and reliable scientific evidence when making any other health-related product claims. It requires the respondents to pay $30,000 to the FTC and notify consumers of the Commission’s order.